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Abstract
Background: This study evaluates HbA1c measure-
ments from dried blood spots collected on filter paper
and compares HbA1c from filter paper (capillary
blood) with HbA1c measured in venous blood.
Methods: Patient satisfaction was evaluated using a
questionnaire. The performance with the filter paper
method was assessed by comparing HbA1c results
from EDTA-blood samples obtained via dried blood
spots with HbA1c results obtained with freshly hemo-
lyzed blood (routine HbA1c). Adult patients visiting
the outpatient clinic for HbA1c analyses were recruit-
ed for the evaluation of dried blood spot sampling at
home. Laboratory personnel collected a capillary
blood sample on filter paper as well as a venous
EDTA-blood sample. The participants collected anoth-
er capillary blood sample at home and sent the dried
filter paper back to the laboratory. Samples were ana-
lyzed with an immunoturbidimetric assay.
Results: Between-filter coefficient of variation was
1.8%. Filter paper HbA1c increased slightly during
storage, particularly during the first 5 days. Filter
paper HbA1c highly correlated with routine HbA1c
(rs0.987). The evaluation of samples collected at
home showed comparable HbA1c values by filter
paper and routine sampling methods (ns93). Eighty-
three percent of participants said they would like the
filter method to be brought into practice.
Conclusions: Home HbA1c sampling on filter paper is
an acceptable sampling alternative for analysis of
HbA1c.
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Introduction
Diabetes mellitus is a major health problem world-
wide. In 2007, it was estimated that ;246 million
adults (7.3%) have diabetes mellitus, with 85%–
95% having type 2 diabetes. European and North
American regions have the highest prevalence at
8.4% and 9.2%, respectively (1). Tight glycemic con-
trol of patients with diabetes mellitus is important
since it reduces the risk of diabetic complications,
including microvascular, neuropathic (2, 3) and
macrovascular (4) complications. Glycemic control is
monitored by measurement of HbA1c content. HbA1c
is the main glycated hemoglobin fraction, formed by
the irreversible binding of glucose to the N-terminal
valine of the b-chains of normal adult hemoglobin
(HbA). HbA1c reflects mean blood glucose concentra-
tions over the previous 1–2 months, and forms an
integral part of diabetes monitoring (5, 6). It is rec-
ommended that HbA1c be measured every 6 months
in patients with stable glycemic control, and every 3
months during changes in treatment or for those who
do not meet treatment goals (5). The American Dia-
betes Association recommends maintaining HbA1c as
close to normal (-6%) without significant hypogly-
cemia as optimal (5). However, many official institutes
recommend an HbA1c level below 7% as being desir-
able for adults (6). HbA1c is generally measured when
the patient visits his or her physician for evaluation of
treatment. Most laboratory HbA1c assays are too
laborious to provide fast HbA1c results, and results
are usually reported after the patient has visited his
doctor. Home sampling devices allow HbA1c samples
to be collected, transported and analyzed a few days
before a patient visits the physicians’ office. These
methods allow patients to take their own capillary
blood at home, and this eliminates a visit to the lab-
oratory before visiting the physician. Potential devices
for collection are EDTA cups or filter paper. Filter
paper is easy to handle, can be sent in flat envelopes
and is inexpensive. An alternative to home sampling
devices is point-of-care testing (POCT). Unlike POCT,
filter HbA1c is measured by the same analytical meth-
od as measurement performed with venous EDTA-
blood for HbA1c. This helps avoid bias between
analytical methods and eliminates the need for peri-
odic method comparison studies. This study com-
pares HbA1c from dried capillary blood on filter
paper, taken by laboratory personnel and by patients
themselves, with HbA1c from freshly hemolyzed
venous EDTA-blood samples. We also evaluated the
satisfaction of patients with this home HbA1c sam-
pling procedure.
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Patients and methods
Laboratory evaluation protocol
Filters, samples and analytical methods Optimal elution
conditions, precision and stability for up to 5 days for HbA1c
obtained from dried blood collected on filter papers and the
comparability with routine HbA1c analysis was investigated.
Filter paper was obtained from Roche Diagnostics (HbA1c
via Post, Roche Diagnostics GmbH, Mannheim, Germany).
Additional stability studies of up to 10 days were investigat-
ed with a second type of filter: Whatman 903 specimen
collection paper (Whatman Nederland BV, Den Bosch, The
Netherlands). The Whatman 903 collection paper is imprint-
ed with five half-inch circles and has a wraparound cover to
protect the paper before and after sample collection. EDTA-
blood samples from anonymized patients were selected
based on previously measured HbA1c concentrations. EDTA-
blood was applied to the filter paper and allowed to dry at
room temperature for at least 3 h. Stored samples were
placed in a dark environment. Discs, 3 mm in diameter, were
punched out of the filter paper, put in hemolyzing
buffer (cat nr. 1488457, Roche, 1 disc per 250 mL) and were
analyzed with the immunoturbidimetric Tinaquant HbA1c
assay on a MODULAR P-analyzer (Roche Diagnostics GmbH,
Mannheim, Germany). Routine HbA1c measurements were
performed by analyzing a mixture of 10 mL EDTA-blood with
1000 mL hemolyzing buffer with the Tinaquant HbA1c
assay.
The initial laboratory evaluations (precision and stability)
employed a 24 h elution period at 48C, according to elution
conditions reported by Jeppsson (7). To improve the logis-
tical processes in our laboratory, we also investigated the
possibility of eluting filters for 1, 2, 3 h at room temperature.
Filters for studies performed following this evaluation were
eluted for 1 h at room temperature (additional stability stud-
ies, method comparison and home sampling evaluation).
Elution conditions Ten EDTA-samples were selected and
spotted on Post filters. Discs were punched out, placed in
hemolyzing buffer and eluted for 24 h at 48C, or for 1, 2 or
3 h at room temperature prior to HbA1c analyses. A minimal
elution period of 1 h was previously reported by Jeppsson
(7) using the same filter and elution buffer.
Precision For precision studies, 20 samples were analyzed
in duplicate by the routine method, or in duplicate from two
Roche filter papers to calculate within- and between-filter
precision. Calculations were performed according to CLSI
EP5 (8). All discs were eluted for 24 h at 48C, according to
elution conditions reported by Jeppsson (7).
Stability Based on the stability studies of Jeppsson (7), we
initially employed a limited study protocol to ensure the sta-
bility of HbA1c from dried blood spots. We analyzed blood
spots from 10 patients (Roche filters) after storage for 0, 1
and 5 days in the dark at room temperature. Discs were sub-
sequently punched out and left to elute for 24 h at 48C prior
to analyses.
Additional stability studies Stability for up to 10 days was
investigated using Whatman 903 filter paper. We analyzed
blood spots from 10 patients (two filter papers per patient)
stored for 0, 1, 5, 7, 8, 9 and 10 days at room temperature.
To investigate the influence of exposure of the filter papers
to air, one filter paper from each patient was stored exposed
to air and the other was stored in a sealed plastic bag. Discs
were punched out and eluted for 1 h at room temperature
prior to analysis.
Method comparison We compared HbA1c concentrations
using the routine method and using dried blood spots from
filter paper. We analyzed the HbA1c concentrations of all
EDTA samples collected during one day in our hospital lab-
oratory using the routine whole blood hemolysate and blood
collected on filter paper (Roche). Discs were eluted for 1 h
at room temperature prior to analysis.
Evaluation of home sampling and patient
satisfaction
Participants were recruited from patients visiting the out-
patient clinic for HbA1c analysis. Patients aged G18 years
and familiar with taking their own capillary blood samples
for home glucose monitoring were eligible for participation.
The study was approved by the Medical Ethics Committee
of the Medical Center Leeuwarden (The Netherlands). Vol-
unteers gave written informed consent prior to participation.
Immediately following collection of a venous EDTA-blood
sample for their routine HbA1c analysis, laboratory person-
nel collected a capillary blood sample which was applied to
filter paper and allowed to dry for at least 3 h. Participants
were also asked to spot filter paper with capillary blood at
home. For this, they received information on the proper pro-
cedure for blood collection and a package that contained a
filter, envelope and written instructions. Participants were
instructed to take a blood sample immediately after arrival
at home, to let the filter dry for at least 3 h and to send it
back to the laboratory in a sealed plastic cover that same
day. On warm days ()258C), participants were instructed to
post the sample a short time before the mailbox was emp-
tied. Patients also received a questionnaire regarding their
satisfaction with the procedure. EDTA-blood samples were
analyzed on the day of sampling according to our routine
procedure (see procedure above). Following arrival to the
laboratory, filters were stored in sealed plastic covers in the
dark at room temperature until analysis. All filters were ana-
lyzed within 10 days by placing one disc into 250 mL hemo-
lyzing buffer, and letting the sample elute for 1 h at room
temperature.
Data analysis
Data were analyzed using the Analyse-It (Analyse-it software,
Ltd., Leeds, UK) and Excel software (Microsoft Corporation,
Redmond, WA, US). Precision was calculated using ANOVA
wCLSI EP5 protocol (8)x and agreement with Passing and
Bablok regression analysis wCLSI EP9 protocol (9)x. Student’s
t-test was used to investigate differences between groups
and paired Student’s t-test was used for differences between
paired samples. Pearson’s correlation coefficient was used
to investigate the relationship between HbA1c and any devi-




Elution conditions The mean HbA1c concentration
of the selected EDTA samples was 7.2% (range
5.0%–9.3%, ns10). Table 1 shows the relative devia-
tion and the relationship between HbA1c measured
from filter paper and our routine HbA1c method
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Table 1 Percentage deviation of HbA1c collected on filter paper from venous HbA1c concentrations and the relationship
between filter paper and baseline venous HbA1c concentrations.
Elution condition Bias, % Correlation
Median wrangex Pearson R
1 h at RT –1.4 w–3.3, 2.0x 0.999
2 h at RT –2.9 w–4.3, 0.0x 0.999
3 h at RT –3.2 w–6.6, 0.0x 0.997
24 h at 48C –6.1 w–11.0, –2.0x 0.995
Ten EDTA-blood samples were spotted and dried on filter paper and then eluted for 1, 2 and 3 h at room temperature, and
for 24 h at 48C. The median wrangex relative bias and correlation between filter paper and venous HbA1c is presented in the
Table (filter – venous HbA1c). Relationships were evaluated using Passing and Bablok regression analyses and the Pearson
correlation coefficient.
Figure 1 Stability studies.
The Figure displays boxplots of the relative bias to routine HbA1c analysis of HbA1c from dried blood spots stored up to
10 days in the dark at room temperature. Rochesprimary stability study, 10 patients, filter papers stored for 0, 1 and 5 days.
Whatmansadditional stability study, 10 patients (2 filter papers per patient), filter papers stored for 0, 1, 5, 7, 8, 9, 10 days.
The boxes represent medians and interquartile ranges. Outliers are shown as ‘‘q’’ and defined as observations which lie
more than 1.5=the interquartile range (IQR) lower than the first quartile or 1.5=IQR higher than the third quartile.
according to the different elution conditions. HbA1c
concentrations from filter paper agreed most closely
with HbA1c concentrations measured using our rou-
tine method when filter paper was eluted for 1 h at
room temperature (RT).
Precision The 20 EDTA samples that we selected
had a mean HbA1c concentration of 7.2% (range
4.8%–10.9%) when measured using our routine
HbA1c method. The precision of duplicate HbA1c
measurements using our routine analysis method
was 1.1%. Within-filter paper variation was 1.1% and
between-filter variation was 1.8%. Measurement of
HbA1c quality control samples using our routine
HbA1c analysis over a 2-month period showed
between-run coefficients of variation of 1.6% (ns46,
mean HbA1c concentrations5.41%), 1.6% (ns46,
means7.51%) and 1.3% (ns46, means10.65%).
Stability The first stability study showed that HbA1c
concentrations increased in the dried blood spots
from days 0 to 5 (Figure 1). Filter paper HbA1c was
lower compared with routine HbA1c measurements
when analyzed on days 0 and 1 (p-0.05), but not on
day 5.
Additional stability studies Stability results with the
Roche filter paper were confirmed with additional sta-
bility studies using the Whatman 903 filter paper.
HbA1c concentrations increased in dried blood spots
from days 0 to 10, with the largest increases from day
0 to 5 (Figure 1). These changes resulted in a median
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Figure 2 Passing and Bablok regression analysis (A) and
bias plots (B) for home and lab filter paper HbA1c vs. HbA1c
from hemolysate.
The dashed line in Figure 2A indicates perfect agreement
between x and y. The two regression lines for home and lab
filter paper HbA1c are black lines. These are difficult to
discriminate, since these overlap to a large extent.
between-day variation of 3.5% wrange 1.0%–8.0%
(maximum 6.2%, excluding outliers)x. Median
between-day variation for filters stored 5–10 days was
1.7% w0.7%–5.0% (0.7%–3.0%, excluding outliers)x. Fil-
ter paper HbA1c was lower than routine HbA1c when
analyzed on days 0 and 1, and was higher on days
5–10 (p-0.05 for all). Increases in HbA1c were similar
for filters stored exposed to air compared with filters
stored in a sealed plastic bag (all days p)0.05). A
positive correlation was shown between routine
HbA1c measurements and the deviation in filter paper
HbA1c concentrations from routine HbA1c concentra-
tions during days 5–10, but not at days 0 and 1.
(Spearman correlation, p-0.05 for all).
Method comparison The 73 samples had a mean
HbA1c concentration of 6.7% (range 4.7%–9.3%) by
routine HbA1c analysis. HbA1c concentrations meas-
ured using filter paper showed significant correlation
with our routine HbA1c method (Pearson rs0.987).
The intercept w–0.011, 95% confidence interval (CI):
–0.232, q0.183x was not significantly different from
zero, and the slope (0.987, 95% CI: 0.957, 1.019) was
not statistically different from 1.
Evaluation of home sampling and patient
satisfaction
The entire study group was comprised of 93 partici-
pants, 54 males and 39 females. The mean age was
59.1 years (range 23–85 years). Five participants, two
males and three females, did not return the home
sampling filter paper, and four did not return the
questionnaire. Since participants gave written
informed consent, their HbA1c concentrations meas-
ured using the laboratory filter paper and our routine
method were included in the statistical analysis.
Twenty-six percent of participants were reported to
have diabetes mellitus type 1, 64% type 2 and 10%
did not know their diabetes type. Participants had dia-
betes for 0.5–43 years (median 8.0 years). Filter
papers collected at home were analyzed within
10 days after sampling. All samples were sent when
outdoor temperatures ranged from –9 to 118C, and
were stored at 19–238C.
Figure 2 shows the comparison between the routine
HbA1c method and the filter paper method, where
‘‘filter lab’’ indicates blood that was collected by lab-
oratory personnel and ‘‘filter home’’ indicated blood
that was collected at home. Passing and Bablok
regression analysis revealed that both intercepts did
not significantly deviate from zero and both slope
values were not statistically different from 1. No signi-
ficant bias was observed; q0.011 (95% CI: –0.037,
q0.060) between samples collected at home and
–0.025 (–0.072, q0.021) samples collected in the lab
with respect to measured HbA1c concentrations.
The Pearson correlation coefficients were 0.980
(p-0.0001) for both comparisons. The Pearson cor-
relation coefficient for the comparison between ‘‘filter
lab’’ and ‘‘filter home’’ was rs0.977 (p-0.0001).
The questionnaire revealed that many patients
were satisfied with the filter paper method. Of the par-
ticipants that responded, 90% indicated that the
search for an alternative method for sampling is val-
uable, 94% indicated that the instructions for sam-
pling were understandable, 97% said that collection
with filter paper was easy, 96% were satisfied with
home collection, 83% indicated that home collection
in the future is desirable and 83% said that the filter
paper method of collection should be brought in
practice.
Discussion and conclusions
We evaluated the performance of dried blood spots
for analysis of HbA1c and investigated patient satis-
faction with home collection of HbA1c samples. The
first report on measurement of glycated protein from
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dried blood spots was published in 1982 by Goldstein
et al. (10). Since then, others have also demonstrated
that HbA1c can be measured using dried blood spots
with acceptable accuracy and precision by use of ion-
exchange chromatography (7, 11–15), affinity chro-
matography (9, 13), a modified barbituric acid method
(16) and by use of immunoturbidumetric assays (7,
17). The stability of HbA1c in dried blood samples is
the major concern. HbA1c may be formed by in vitro
glycation of hemoglobin, and may also be degraded
during storage in dried blood (18). Our results illus-
trate that pre-analytical factors need to be taken into
account. In particular, storage and elution conditions
were important factors. Storage increased HbA1c
concentrations, whereas prolonged elution times
decreased HbA1c. Both effects may contribute signi-
ficantly to the pre-analytical variation. It has been
shown previously that high blood glucose concentra-
tions increase glycated protein in dried blood samples
(16). Our results confirm this finding, especially when
one considers the positive relationship between
HbA1c concentrations and the changes in HbA1c dur-
ing storage. The increase may be greater at higher
temperatures (14), although no temperature effect
was evident in the study by Jeppsson et al. (12). The
in vitro effects may also depend upon the analytical
method that is used to measure HbA1c (18). Large
clinical trials, such as the Diabetes Control and Com-
plications Trial (2) and the United Kingdom Prospec-
tive Diabetes Study (3), have shown convincingly that
an absolute HbA1c difference of 1% is related to a
significant reduction in risk from microvascular as
well as macrovascular diabetic complications. Within
a single patient, an absolute change of 1% is also con-
sidered to be significant. The within-person biological
variation of HbA1c in non-diabetic individuals is esti-
mated to be very small. These biological factors
demand strict analytical criteria. Currently, the recom-
mended desirable goal for analytical precision is
-3%, with an optimum goal of -2% (19). Standardiz-
ation of procedures and evaluation of the filter
paper method in daily practise is therefore important.
Another option is the use of filter paper pretreated
(13–16, 20) with, for example, glucose oxidase. These
have been shown to enhance the stability of HbA1c
when compared to untreated filter paper. The relative
instability and subsequent variability did not seem to
be a major problem when using filter paper in our
daily practise, given the good agreement between
home filter paper HbA1c and routine HbA1c analyses
(Figure 2). In addition, filter paper HbA1c analyzed
between days 5 and 10 after collection had a median
total analytical variation of 1.7%, which is comparable
to the analytical variation of routine HbA1c analysis.
This figure compares favorably to the 2.7% for
3–10 days storage of the pretreated filter papers that
were stored with an unknown patented solution in the
study of Parkes et al., who used a similar method of
analysis (20).
A review of six studies (21) demonstrated that
immediate availability of HbA1c improves diabetes
management, results in lower HbA1c concentrations
on subsequent visits and influenced clinical manage-
ment in most studies. Kennedy et al. (22) performed
a large randomized controlled study with 7893 adults
and showed that point-of-care measurement of
HbA1c resulted in a significantly higher percentage of
patients achieving HbA1c concentrations below 7%.
Our study showed that many patients supported the
search for an alternative method of collection, and
were satisfied with the filter paper method tested.
Patients are able to send their blood sample by post,
and this method provides an opportunity for the phy-
sician to choose whether he or she wishes to examine
stable patients during a hospital visit. We conclude
that home collection of blood for HbA1c on filter
paper is an acceptable, easy and inexpensive alter-
native for collection of blood samples for HbA1c anal-
ysis when pre-analytical factors are taken into
account.
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